Melo et al. identified glypican-1 (GPC1) as a diagnostic, prognostic, and predictive marker for disease-specific survival in PC (hazard ratio (HR): 5.353, CI: 1.651–17.358, p = 0.005). The gene discussed is GPC1; the disease is pachyonychia congenita.